Rapamycin alleviates alveolitis and pulmonary fibrosis in the BLM-induced pulmonary fibrosis rat model by reducing the production of matrix metalloproteinase (MMP)-9 and tissue inhibitors of MMP-1 in lung tissue [102]. The gene discussed is MMP1; the disease is pulmonary fibrosis.